|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/45 |
| (11) | Patento numeris | 2040548 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07812295.9 |
| Europos patento paraiškos padavimo data | 2007-06-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-04-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-05-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/072016 |
| Data | 2007-06-25 |
| (87) | Numeris | WO 2007/150064 |
| Data | 2007-12-27 |
| (30) | Numeris | Data | Šalis |
| 815952 P | 2006-06-23 | US |
| (72) |
WUSTMAN, Brandon, US
|
| (73) |
Amicus Therapeutics, Inc.,
6 Cedar Brook Drive, Cranbury, NJ 08512,
US
|
| (54) | METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF BETA -GLUCOCEREBROSIDASE |
| METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF BETA -GLUCOCEREBROSIDASE |